Wrango, the healthcare marketing platform built on real-world clinical data, today announced that Thomas Shea has joined the company as its first Chief Revenue Officer. Shea will lead Wrango’s sales and partnerships teams as the company expands its work with pharma brands and the agencies that plan their HCP media.
Pharma marketers are being asked to prove more with less. More proof that media reached real prescribers. More proof it changed what they prescribed. Less budget and less time to show it. Shea has spent his career working with the teams facing that pressure.
A career built in pharma media
Shea most recently served as Chief Revenue Officer at Doceree, where he led revenue for five years. Before that, he was VP of Sales at PulsePoint. He spent eight years at Adprime Health, where he rose from Senior Account Executive to Vice President of Sales for the pharma division.
“Tom has spent his career in the room building with pharma marketers and their agencies. He knows what they’re asked to prove and how hard it is to prove it with the tools they have today,” said Joshua Alvernia, CEO and Co-Founder of Wrango. “He’s the right champion for Wrango as we grow with our customers.”
What Shea will lead
Shea joins as Wrango scales two parts of its platform. Soon-to-Prescribe audiences use real-world claims to find HCPs who are treating relevant patients right now. Wrango’s DTC patient audiences start from those same in-market providers to reach the patients most likely to need the brand, so HCP and consumer media run from one model.
Shea will lead Wrango’s commercial team across the U.S. and Canada, bringing both offerings to more brands and agencies with closed-loop Script Lift measurement tied to real prescription data.
“Wrango has built something truly differentiated in healthcare marketing by combining deep real-world data with true cross-channel activation,” said Thomas Shea, Chief Revenue Officer at Wrango. “I’m thrilled to join at this stage and help drive the next phase of growth for our clients and partners.”
